IMMY is a US-based organization with a dedicated focus in mycology. We develop, manufacture, and distribute innovative diagnostic tests and reagents for fungal diseases.

Explore our range of fungal tests with comprehensive resources and documentation available in multiple languages.

IMMY is a US-based organization focused on mycology. We manufacture, market, and distribute innovative diagnostic tests and reagents for fungal diseases.

The IMMY CrAg LFA provides rapid, accurate detection of cryptococcal meningitis, helping improve outcomes and reduce mortality through early diagnosis.

Explore careers at IMMY, a leader in fungal diagnostics. Join our team of innovators improving global health with cutting-edge diagnostic solutions.

IMMY’s Aspergillus GM LFA provides a rapid, highly sensitive, and specific solution, delivering results in just 45 minutes. This Aspergillus antigen diagnostic test enables clinicians to test …

Detect Histoplasma antigen quickly and accurately with our cost-effective Histoplasma GM EIA, reducing misdiagnoses and improving outcomes in two hours.

Discover IMMY's Latex Agglutination and Immunodiffusion tests for fungal disease detection, with reliable antibody and antigen systems for diagnosis.

Detect cryptococcal meningitis early with IMMY's sensitive antigen test, improving treatment outcomes for HIV/AIDS patients and potentially saving lives.

Real People, Real Results, Real Impact Discover the Life-Saving Potential Reach out to learn how IMMY’s MyccoDDR can improve patient outcomes.